Advertisement

Calcitonin: Analgesic Effects

  • R. Ziegler
Part of the Recent Results in Cancer Research book series (RECENTCANCER, volume 89)

Abstract

Calcitonin was discovered 20 years ago and was first regarded as an osteotropic hypocalcemic hormone, antagonizing parathyroid hormone (Copp 1969). Later, the stimulation of calcitonin secretion by gastrointestinal hormones and the inhibition of the function of several gastrointestinal organs were described (for review, see Ziegler 1981). Presumably, calcitonin is a calcium-conserving hormone at least in mammals. Calcitonin was detected not only in the thyroid C cells, originating from the terminal branchial pouch, but also in the thymus, adrenals, lungs, and the brain (MacIntyre and Stevenson 1981), depending on the species investigated. The hormone is found in primitive prevertebrate organisms, such as Ciona intestinalis, and it is possible that, primarily, it exerts neuroendocrine functions. Later in phylogenesis, it becomes involved in the regulation of bone metabolism after the development of mineralized hard tissue.

Keywords

Acute Pancreatitis Analgesic Effect Salmon Calcitonin Procaine Hydrochloride Human Calcitonin 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Barreca T, Cicchetti M, Magnani G, Sannia A, Rolandi E (1979) Effects of long-term treatment with porcine calcitonin in patients suffering from neoplastic osteolysis. Curr Ther Res 26: 644–649Google Scholar
  2. Behn AR, West TET (1977) Emergency treatment with calcitonin of hypercalcemia associated with multiple myeloma. Br Med J 1: 755–756PubMedCrossRefGoogle Scholar
  3. Braga P, Ferri S, Santagostino A, Olgiati VR, Pecile A (1978) Lack of opiate receptor involvement in centrally induced calcitonin analgesia. Life Sci 22: 971–978PubMedCrossRefGoogle Scholar
  4. Cesarini F, Colombo M, Olgiati VR, Pecile A (1979) Calcitonin and prostaglandin systems. Life Sci 25: 1851CrossRefGoogle Scholar
  5. Chiarini P, Matassi L, Fabrizi G (1978) Calcitonin and somatic pain: effect of the hormone on the algogenic component of experimental skin inflammation induced by cantharidin. Curr Ther 86: 451–463Google Scholar
  6. Copp DH (1969) Endocrine control of calcium homeostasis. J Endocrinol 43: 137–161PubMedCrossRefGoogle Scholar
  7. Di Silverio F, Giacobini S, Liberti M, Fragomeri R, Petrone U (1977) Impiego della calcitonia nelle metastasi ossie da carcinoma della prostata. Clin Ter 83: 3–15PubMedGoogle Scholar
  8. Fabbri A, Santoro C, Moretti C, Cappa M, Fraioli F, Di Julio GP, Galluzi T, La Manna V (1981) The analgesic effect of calcitonin in humans: studies on the role of opioid peptides. Int J Clin Pharmacol Ther Toxicol 19: 509–511PubMedGoogle Scholar
  9. Favini G, Arosio A, Libretti A (1979) Bone metastases from breast cancer treated with calcitonin. Case report. Tumori 65: 713–717Google Scholar
  10. Gennari C (1980) Calcitonin and bone metastases of cancer. In: Pecile A (ed) Calcitonin 1980. Excerpta Medica, Amsterdam, pp 277–287Google Scholar
  11. Goebell H, Amman R, Herfarth Ch, Horn J, Hotz J, Knoblauch M, Schmid M, Jaeger M, Akovbiantz A, Linder E, Abt K, Nüesch E, Barth EA (1979) A double blind trial of synthetic salmon calcitonin in the treatment of acute pancreatitis. Scand J Gastroenterol 14: 881–889PubMedCrossRefGoogle Scholar
  12. Kanis JA (1976) Bone disease and calcitonin. Armour, Eastbourne Leyland MJ, Hindley A (1982) Calcitonin in the management of malignant bone pain. Clin Sci 62: 43 PGoogle Scholar
  13. Maclntyre I (1977) Human calcitonin and Paget’s disease. Huber, BernGoogle Scholar
  14. MacIntyre I, Stevenson JC (1981) Calcitonin: a modern view of its physiological role and interrelation with other hormones. In: Pecile A (ed) Calcitonin 1980. Excerpta Medica, Amsterdam, pp 1–10Google Scholar
  15. Nakamuta H, Furukawa S, Koida M, Yajima H, Orlowski RC, Schlueter R (1981) Specific binding of 1-salmon calcitonin to rat-brain: regional variation and calcitonin specificity. Jpn J Pharmacol 31: 53–60PubMedCrossRefGoogle Scholar
  16. Paul F, Ohnhaus EE, Hesch RD, Chemnitz G, Hoppe-Seyler R, Henrichts HR, Hartung H, Waldmann D, Kunzek K, Barth E, Nüesch E, Abt K (1979) Einfluß von Salm-Calcitonin auf den Verlauf der akuten Pankreatitis. Dtsch Med Wochenschr 104: 615–622PubMedCrossRefGoogle Scholar
  17. Pecile A, Ferri S, Santagostino A, Olgiati VR (1975) Effects of intraventricular calcitonin in the conscious rat. Experientia 31: 332–333PubMedCrossRefGoogle Scholar
  18. Pietrogrande V (1976) Il trattamento dell’ osteoporosi con Calcitonina. Fondazione Carlo Erba, MilanoGoogle Scholar
  19. Rojanasathit S, Rosenberg E, Haddad JG (1974) Paget’s bone disease: response to human calcitonin in patients resistant to salmon calcitonin. Lancet 2: 1412–1415PubMedCrossRefGoogle Scholar
  20. Schedel I (1982) Calcitonin bei Knochenschmerzen bei multiplem Myelom. Symposium Beeinflussung von Schmerzen durch Calcitonin, Heidelberg, 20 May 1982 (abstract)Google Scholar
  21. Vignon E, Chapuy MC, Courpron P, Colombet P, Meunier P (1977) Effets cliniques et biologiques de la calcitonine synthétique de saumon dans les algodystrophies des membres. Lyon Med 237: 291–295Google Scholar
  22. Welzel D (1982) Postoperative Schmerzen. Symposium-Beeinflussung von Schmerzen durch Calcitonin, Heidelberg, 20 May 1982 (abstract)Google Scholar
  23. Yamamoto M, Kumagai F, Tachikawa S, Murayama S (1978) Effects of porcine calcitonin on various analgesic responses in mice and rabbits. Ciba Med J 54: 27–33Google Scholar
  24. Yamamoto M, Kumagai F, Tachikawa S, Maeno H (1979) Lack of effect of levallorphan on analgesia induced by intraventricular application of porcine calcitonin in mice. Eur J Pharmacol 55: 211–213PubMedCrossRefGoogle Scholar
  25. Ziegler R (1981) Calcitonin. Sandoz, NürnbergGoogle Scholar
  26. Ziegler R, Holz G, Raue F, Minne H, Delling G (1977) Therapeutic studies with human calcitonin. In: Maclntyre J (ed) Human calcitonin and Paget’s disease. Huber, Bern, pp 167–178Google Scholar
  27. Ziegler R, Raue F, Holz G, Minne H (1980) Calcitonin and the endocrine pancreas. In: Pecile A (ed) Calcitonin 1980. Excerpta Medica, Amsterdam, pp 314–325Google Scholar

Copyright information

© Springer-Verlag Berlin · Heidelberg 1984

Authors and Affiliations

  • R. Ziegler
    • 1
  1. 1.Medizinische Poliklinik, Abteilung für Innere Medizin VI (Endokrinologie)Ruprecht-Karls-Universität HeidelbergHeidelberg 1Germany

Personalised recommendations